The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer.

Xu, Yichi; Song, Gendi; Xie, Shangdan; Jiang, Wenxiao; Chen, Xin; Chu, Man; Hu, Xiaoli; Wang, Zhi-Wei

Xu, Yichi; Song, Gendi; Xie, Shangdan; Jiang, Wenxiao; Chen, Xin; Chu, Man; Hu, Xiaoli; Wang, Zhi-Wei.

Afiliação

Xu Y; Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
Song G; Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
Xie S; Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
Jiang W; Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
Chen X; Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
Chu M; Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
Hu X; Department of Obstetrics and Gynecology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China. Electronic address: wmuhuxiaoli2020@163.com.
Wang ZW; Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Center of Scientific Research, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China. Electronic address: zhiweichina@126.co

Mol Ther ; 29(6): 1958-1969, 2021 06 02.

Article em En | MEDLINE | ID: mdl-33932597

Assuntos

Antineoplásicos Imunológicos/uso terapêutico; Antígeno B7-H1/metabolismo; Biomarcadores Tumorais; Receptor de Morte Celular Programada 1/metabolismo; Neoplasias da Próstata/metabolismo; Neoplasias da Próstata/mortalidade; Neoplasias da Próstata/terapia; Antineoplásicos Imunológicos/farmacologia; Antígeno B7-H1/genética; Terapia Combinada; Desenvolvimento de Medicamentos; Regulação Neoplásica da Expressão Gênica; Humanos; Imunoterapia; Interleucina-6/metabolismo; Janus Quinases/metabolismo; Masculino; Terapia de Alvo Molecular; Prognóstico; Receptor de Morte Celular Programada 1/genética; Neoplasias da Próstata/etiologia; RNA Interferente Pequeno/genética; Transdução de Sinais/efeitos dos fármacos; Resultado do Tratamento

Palavras-chave

PD-1; PD-L1; immunotherapy; prostate cancer; vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google